JPWO2022249071A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022249071A5 JPWO2022249071A5 JP2023572876A JP2023572876A JPWO2022249071A5 JP WO2022249071 A5 JPWO2022249071 A5 JP WO2022249071A5 JP 2023572876 A JP2023572876 A JP 2023572876A JP 2023572876 A JP2023572876 A JP 2023572876A JP WO2022249071 A5 JPWO2022249071 A5 JP WO2022249071A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- score
- pharmaceutical composition
- nash crn
- nash
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163194088P | 2021-05-27 | 2021-05-27 | |
| US63/194,088 | 2021-05-27 | ||
| PCT/IB2022/054867 WO2022249071A1 (en) | 2021-05-27 | 2022-05-25 | Pemafibrate and/or tofogliflozin for use in treating liver disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024520020A JP2024520020A (ja) | 2024-05-21 |
| JPWO2022249071A5 true JPWO2022249071A5 (https=) | 2025-05-08 |
| JP2024520020A5 JP2024520020A5 (https=) | 2025-05-08 |
Family
ID=82020168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572876A Pending JP2024520020A (ja) | 2021-05-27 | 2022-05-25 | 肝疾患の治療における使用のためのペマフィブラートおよび／またはトホグリフロジン |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240277745A1 (https=) |
| EP (1) | EP4346809A1 (https=) |
| JP (1) | JP2024520020A (https=) |
| KR (1) | KR20240013203A (https=) |
| CN (1) | CN117677385A (https=) |
| AU (1) | AU2022282651A1 (https=) |
| BR (1) | BR112023024701A2 (https=) |
| CA (1) | CA3221073A1 (https=) |
| MX (1) | MX2023013886A (https=) |
| WO (1) | WO2022249071A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4556006A4 (en) * | 2022-07-15 | 2026-01-07 | Kowa Co | MEDICATION TO LOWER LDL CHOLESTEROL IN THE BLOOD |
| CN115991682A (zh) * | 2023-03-21 | 2023-04-21 | 广州佳途科技股份有限公司 | 一种培马贝特-d4的制备方法及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI696462B (zh) | 2013-07-10 | 2020-06-21 | 日商興和股份有限公司 | 非酒精性脂肪性肝疾病治療劑 |
| WO2018131626A1 (ja) | 2017-01-11 | 2018-07-19 | 興和株式会社 | 非アルコール性脂肪性肝疾患の予防及び治療薬 |
-
2022
- 2022-05-25 US US18/564,115 patent/US20240277745A1/en active Pending
- 2022-05-25 AU AU2022282651A patent/AU2022282651A1/en active Pending
- 2022-05-25 BR BR112023024701A patent/BR112023024701A2/pt unknown
- 2022-05-25 EP EP22729797.5A patent/EP4346809A1/en active Pending
- 2022-05-25 CA CA3221073A patent/CA3221073A1/en active Pending
- 2022-05-25 JP JP2023572876A patent/JP2024520020A/ja active Pending
- 2022-05-25 CN CN202280050095.0A patent/CN117677385A/zh active Pending
- 2022-05-25 WO PCT/IB2022/054867 patent/WO2022249071A1/en not_active Ceased
- 2022-05-25 KR KR1020237044685A patent/KR20240013203A/ko active Pending
- 2022-05-25 MX MX2023013886A patent/MX2023013886A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6250588B2 (ja) | Ｌ−オルニチンフェニル酢酸塩を用いる門脈圧亢進の治療及び肝機能の修復 | |
| US9962346B2 (en) | Treatment of NAFLD and NASH | |
| JP7369033B2 (ja) | 線維症の治療 | |
| KR102876077B1 (ko) | 간 질환을 치료하기 위한 병용 요법 | |
| US20130316994A1 (en) | Methods of Reducing Risk of Hepatobiliary Dysfunction During Rapid Weight Loss with METAP-2 Inhibitors | |
| KR102000332B1 (ko) | 간내 담즙정체성 질환의 치료 | |
| CN113301889A (zh) | Nafld和nash的联合治疗 | |
| JP7617898B2 (ja) | Ｅｙｐ００１を使用した改善された処置 | |
| TWI908718B (zh) | 類鐸受體促效劑給藥方案 | |
| WO2019024758A1 (zh) | 一种糖苷类化合物在制备用于治疗肝纤维化药物中的应用 | |
| WO2008073779A2 (en) | Compositions and methods for treating seizures | |
| JPWO2022249071A5 (https=) | ||
| JP2002524417A5 (https=) | ||
| CA3116793C (en) | Medical use of anemoside b4 against acute gouty arthritis | |
| WO2022161468A1 (en) | Compositions of berberine ursodeoxycholate and methods thereof for treating primary sclerosing cholangitis | |
| RU2023135081A (ru) | Пемафибрат и/или тофоглифлозин для лечения заболевания печени | |
| CN114522160A (zh) | Lz01在治疗杜氏肌营养不良症中的应用 | |
| CN114588164A (zh) | 瑞马唑仑在预防围术期低体温和寒战中的应用 | |
| JP4370054B2 (ja) | 腸粘膜傷害の予防及び治療剤 | |
| RU2784896C2 (ru) | Медицинское применение анемозида b4 против острого подагрического артрита | |
| JP2002114672A (ja) | Ｃ型又は非ｂ非ｃ型肝炎ウイルスによる肝機能異常の改善剤 | |
| JPWO2021076766A5 (https=) | ||
| JPWO2022245933A5 (https=) | ||
| CN118203578A (zh) | 奥赛利定在制备预防或治疗围术期低体温的药物中的应用 | |
| CN121243146A (zh) | 3,5-二甲氧基-4-(2-氨基-3-(2-炔-丙硫烷)-丙酰基)-苯甲酸4-胍基-丁酰酯在医学中的新应用 |